4.7 Article

Heterogeneity of Altered Cytokine Levels Across the Clinical Spectrum of Diabetes in China

期刊

DIABETES CARE
卷 34, 期 7, 页码 1639-1641

出版社

AMER DIABETES ASSOC
DOI: 10.2337/dc11-0039

关键词

-

资金

  1. European Foundation for the Study of Diabetes (EFSD)
  2. Bristol-Myers Squibb Company
  3. Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province
  4. National Science Foundation [30831160518]

向作者/读者索取更多资源

OBJECTIVE-To determine the relationship between selected cytokines and diabetes in Chinese subjects. RESEARCH DESIGN AND METHODS-Adult patients with recent-onset type I diabetes (n = 53), latent autoimmune diabetes in adults (LADA) (n = 250), and type 2 diabetes (n = 285) from multiple centers were compared with normal subjects (n = 196). We centrally tested serum GAD antibodies (GADAs), interleukin-6 (IL-6), lipocalin 2 (LCN2), high-sensitivity C-reactive protein (hs-CRP), and adiponectin. RESULTS-After adjustment for age, sex, and BMI, all diabetes types had increased IL-6 and LCN2 (P < 0.01), and all four cytokines were increased in LADA (P < 0.01). In type 1 diabetes, adiponectin but not hs-CRP was increased (P < 0.01), whereas in type 2 diabetes, hs-CRP but not adiponectin was increased (P < 0.01). Adiponectin was correlated positively with GADA titer and negatively with hs-CRP (P < 0.01 for both). CONCLUSIONS-In China, inflammatory markers are increased in all three major types of diabetes, but probably for different reasons, even in autoimmune diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据